HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea flag South Korea · Delayed Price · Currency is KRW
18,510
-900 (-4.64%)
Apr 16, 2026, 3:30 PM KST

HLB Pharmaceutical Market Cap

HLB Pharmaceutical has a market cap or net worth of 259.92 billion as of April 16, 2026. Its market cap has decreased by -24.14% in one year.

Market Cap
259.92B
Enterprise Value
258.47B
Revenue
205.58B
Ranking
n/a
PE Ratio
132.21
Stock Price
18,510.00

Market Cap Chart

Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 259.92B, an increase of 208.40%. That is a compound annual growth rate of 11.53%.

History

DateMarket Cap% Change
Apr 15, 2026272.56B21.01%
Dec 30, 2025225.24B-33.44%
Dec 30, 2024338.42B58.45%
Dec 28, 2023213.58B43.49%
Dec 29, 2022148.85B-21.48%
Dec 30, 2021189.57B-21.05%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Yungjin Pharm.324.09B
Huons306.44B
JW Holdings295.44B
Korea United Pharm294.37B
CMG Pharmaceutical268.19B
BNC Korea262.64B
Boditech Med240.68B
Hyundai Pharmaceutical236.64B
Market Cap Rankings